National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 1107275

History of Changes from the VAERS Wayback Machine

First Appeared on 6/25/2021

VAERS ID: 1107275
VAERS Form:2
Age:97.0
Sex:Female
Location:Foreign
Vaccinated:2021-03-02
Onset:2021-03-02
Submitted:0000-00-00
Entered:2021-03-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EP2163 / 1 - / -

Administered by: Other      Purchased by: ??
Symptoms: Blood bicarbonate, Blood gases, Chest X-ray, Chronic respiratory failure, Electrocardiogram, Heart rate, Lower respiratory tract infection, PCO2, Physical examination, PO2, Respiratory acidosis, Cardiac monitoring, pH body fluid, Bronchial hyperreactivity, Auscultation, SARS-CoV-2 test

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: BIRESP SPIROMAX; PECTOX LISINA; SIMVASTATINA; DELTIUS; METAMIZOLUM; CARVEDILOL; FUROSEMIDA [FUROSEMIDE]; AMLODIPINO [AMLODIPINE]; NITROGLYCERIN TRANSDERMAL SYSTEM; TRAZODONA [TRAZODONE]; EUTIROX; OMEPRAZOL; ADIRO; IRBESARTAN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Cardiac failure congestive (congestive heart failure); Chronic respiratory failure; COPD; COVID-19; Cyanosis of lip; Diabetes (Type II diabetes); Difficulty in walking; Feeling bad (felt strange); Fractured vertebra (compression); Hyperglycemia; Hypertension arterial (HTA); Hypertensive crisis; Pale; Paroxysmal atrial fibrillation; Pulmonary hypertension; Respiratory infection (treatment by her primary care doctor with bronchodilators and azithromycin); Stupor
Allergies:
Diagnostic Lab Data: Test Name: Lung auscultation; Result Unstructured Data: Test Result:expiratory wheezing in both lung fields, rales in; Comments: expiratory wheezing in both lung fields, rales in the left field; Test Name: HCO3; Result Unstructured Data: Test Result:32.3; Test Name: arterial blood gas test; Result Unstructured Data: Test Result:2 L/min; Comments: base excess 5.9; Test Name: Cardiac auscultation; Result Unstructured Data: Test Result:rscsrs; Test Name: Rx thorax; Result Unstructured Data: Test Result:increased density in right midfield; Comments: increased density in right midfield with bilateral redistribution; Test Name: ECG; Result Unstructured Data: Test Result:HB 78 bpm; Test Name: Heartbeat; Result Unstructured Data: Test Result:78 bpm; Test Name: pCO2; Result Unstructured Data: Test Result:69.3; Test Name: pH; Result Unstructured Data: Test Result:7.29; Test Name: physical exam; Result Unstructured Data: Test Result:conscious, oriented and collaborative; Comments: conscious, oriented and collaborative. Good hygiene and good presence. Tachypneic. Cardiac auscultation: rscsrs. Lung auscultation: expiratory wheezing in both lung fields, rales in the left field. Globular abdomen, soft, depressible, not painful, without defense or signs of peritonism. Lower extremities: bilateral pitting edema; Test Name: pO2; Result Unstructured Data: Test Result:84; Test Name: COVID-19 PCR test; Result Unstructured Data: Test Result:negative
CDC 'Split Type': ESPFIZER INC2021250306

Write-up: low respiratory infection and chronic respiratory failure exacerbated with respiratory acidosis; low respiratory infection and chronic respiratory failure exacerbated with respiratory acidosis; low respiratory infection and chronic respiratory failure exacerbated with respiratory acidosis; Bronchial hyperreactivity/Bronchial hyperresponsiveness; This is a spontaneous report from a contactable physician downloaded from The Regulatory Authority-WEB ES-AEMPS-774329. A 97-year-old female patient received the first dose of bnt162b2 (COMIRNATY, lot number: EP2163), via an unspecified route of administration on 02Mar2021 at single dose for COVID-19 immunisation. Medical history included Type II diabetes; hypertension arterial (HTA); TVP years ago; COPD probably secondary to pulmonary HT with O2-home therapy at 1.5 bpm; lumbar vertebral compression fracture; admission in Mar2020 for hypertensive crisis, hyperglycemia, reversed paroxysmal atrial fibrillation after amiodarone infusion, secondary myocardial damage, cardiac failure congestive (congestive heart failure) and exacerbated chronic respiratory failure. Admitted to the hospital for COVID 19 pneumonia in April 2020. Concomitant medication included budesonide, formoterol fumarate (BIRESP SPIROMAX 160 ug/4.5 ug), carbocisteine lysine (PECTOX LISINA), simvastatina, colecalciferol (DELTIUS), metamizolum, carvedilol, furosemide (FUROSEMIDA), amlodipine (AMLODIPINO), glyceryl trinitrate (NITROGLYCERIN TRANSDERMAL SYSTEM), trazodone (TRAZODONA), levothyroxine sodium (EUTIROX, 25 ug), omeprazole (OMEPRAZOL), acetylsalicylic acid (ADIRO), and irbesartan. After administering the first dose of COVID-19 Pfizer-Bi vaccine, the patient presented a picture of discomfort, with paleness, labial cyanosis and doubtful loss of consciousness. Not accompanied by other clinical background. The relative comments that before the vaccination she had already "felt strange." They also refer to finding her stuporous with paleness and labial cyanosis. The daughter refers that before the injection she had been feeling bad and she walked worse. Focal deficits are not reported. No fever. She has been treated with methylprednisolone and high-flow O2. Last week treatment by her primary care doctor with bronchodilators and azithromycin for suspected respiratory infection. Evolution in the Emergency Department: A control arterial blood gas test was performed without evident improvement, persistent hypercapnia without hypoxemia. Neurologically, she remains awake without drowsiness. The patient suffers abrupt respiratory deterioration, while waiting for admission to the internal medicine ward, entering respiratory arrest finally ending death despite attempted ventilatory resuscitation. Diagnosis: Bronchial hyperresponsiveness/ bronchial hyperreactivity on 02Mar2021. Doubtful post-vaccination reaction: low respiratory infection and chronic respiratory failure exacerbated with respiratory acidosis. Physical examination: conscious, oriented and collaborative. Good hygiene and good presence. Tachypneic. Cardiac auscultation: rscsrs. Lung auscultation: expiratory wheezing in both lung fields, rales in the left field. Globular abdomen, soft, depressible, not painful, without defense or signs of peritonism. Lower extremities: bilateral pitting edema. Radiology: Chest X-ray: increased density in the middle right field with bilateral redistribution. Other tests: ECG: heartbeat at 78 bpm. Arterial blood gas test at 2 L / min: pH 7.29, pCO2 69.3, pO2 84, HCO3 32.3, base excess 5.9. PCR SARS-COV-2 Negative. The patient died on an unspecified date due to bronchial hyperreactivity/bronchial hyperresponsiveness. It was not reported if an autopsy was performed. The outcome of the event low respiratory infection and chronic respiratory failure exacerbated with respiratory acidosis was unknown. No follow-up attempts are possible, no information is expected.; Reported Cause(s) of Death: Bronchial hyperreactivity/Bronchial hyperresponsiveness

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=1107275&WAYBACKHISTORY=ON

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166